| Prev Close: | 6.04 |
|---|---|
| Open: | 6.09 |
| Bid: | 6.02 x 500 |
| Ask: | 6.18 x 5000 |
| 1y Target Est: | 10.57 |
| Beta: | 2.69 |
| Next Earnings Date: | 7-Aug-13 |
| Day's Range: | 6.01 - 6.17 |
|---|---|
| 52wk Range: | 3.10 - 7.73 |
| Volume: | 521,454 |
| Avg Vol (3m): | 1,123,730 |
| Market Cap: | 569.74M |
| P/E (ttm): | N/A |
| EPS (ttm): | -1.29 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- The 9 Most Obese Countries in the Worldat Motley Fool(Mon 2:06PM EDT)
- Orexigen Therapeutics to Present at the UBS Global Healthcare ConferencePR Newswire(Fri May 17)
- Due Diligence in Finding the Value of Pharmaceuticals: Expert Portfolio Manager Finny Kuruvilla Discusses His Portfolio Construction Strategy with The Wall Street TranscriptWall Street Transcript(Thu May 16)
- Orexigen Therapeutics' Management Presents at Bank of America Merrill Lynch Health Care Conference - Transcriptat Seeking Alpha(Wed May 15)
- Weight Loss Isn't Just for Looking Good Anymoreat Motley Fool(Wed May 15)
- OREXIGEN THERAPEUTICS, INC. FinancialsEDGAR Online Financials(Wed May 15)
- Will Obesity Drugs Gain Soon?at Motley Fool(Wed May 15)
- Looking at Arena Following Sell-Offat Motley Fool(Tue May 14)
- Vivus Starting To Gain The Advantage Over Arenaat Seeking Alpha(Tue May 14)
- SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Orexigen Therapeutics, Inc.Business Wire(Mon May 13)
- Why Does Arena's Obesity Drug Have Abuse Potential?at Forbes(Sat May 11)
- Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care ConferencePR Newswire(Fri May 10)
- ARNA Sheds Light on Belviq LaunchZacks(Thu May 9)
- VIVUS Reports Wider LossZacks(Thu May 9)
- OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu May 9)
Press Releases
- MDT, HLF, OREX, and NVS Early Briefing and ReviewAccesswire(Mon May 6)
- Equities Review and Reports For (NYSE: RDN) (NASDAQ: OREX)Accesswire(Fri Apr 26)
- Trader’s Favourite Stocks: Amazon.com, Microsoft Corporation, Orexigen Therapeutics, Nokia CorporationAccesswire(Thu Sep 6)
Must Read
- Global shares grind higher, yen rebounds on minister's remarksReuters(1969-12-31T18:59:59GMT-05:00)
- Former Montana Gov. Schweitzer elected chairman of mining company; Senate run still possibleThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Special K churning out new products as part of shift into a weight management toolThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Chesapeake Energy hires Anadarko executive as CEOReuters(1969-12-31T18:59:59GMT-05:00)
- Despite talk of Fed changing tack, investors have so far refrained from big profit-takingThe Canadian Press(1969-12-31T18:59:59GMT-05:00)